Shopping Cart
- Remove All
- Your shopping cart is currently empty
TLR9-IN-1 (compound 29) is an effective and selective TLR9 inhibitor with an IC50 of 7 nM in human B cells, suitable for autoimmune diseases and inflammation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 8-10 weeks | |
50 mg | $1,980 | 8-10 weeks | |
100 mg | $2,500 | 8-10 weeks |
Description | TLR9-IN-1 (compound 29) is an effective and selective TLR9 inhibitor with an IC50 of 7 nM in human B cells, suitable for autoimmune diseases and inflammation. |
Targets&IC50 | HEK/hTLR9:7 nM |
In vitro | TLR9-IN-1 (0-10 μM, 24 hours) treated human monocytes showed moderate inhibitory activity against IL-1β in cells, with an IC50 of 1.61 μM in human monocytes (co-incubated with TLR8 agonist ORN8L and RNA oligonucleotides). [1] |
Synonyms | TLR9-IN1 |
Molecular Weight | 421.54 |
Formula | C23H31N7O |
Cas No. | 2226366-86-3 |
Smiles | O=C(NCCCN(C)C)C1CCN(C2=NN=CC3=CN(N=C32)C4=CC=C(C=C4)C)CC1 |
Color | Yellow |
Appearance | Solid |
Storage | keep away from direct sunlight | store at 4°C | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 420 mg/mL (996.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.